Annual Short Term Debt
$9.16 M
+$1.46 M+18.93%
December 31, 2023
Summary
- As of February 8, 2025, NRXP annual short term debt is $9.16 million, with the most recent change of +$1.46 million (+18.93%) on December 31, 2023.
- During the last 3 years, NRXP annual short term debt has risen by +$8.91 million (+3579.12%).
- NRXP annual short term debt is now at all-time high.
Performance
NRXP Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Short Term Debt
$3.68 M
-$3.97 M-51.85%
September 30, 2024
Summary
- As of February 8, 2025, NRXP quarterly short term debt is $3.68 million, with the most recent change of -$3.97 million (-51.85%) on September 30, 2024.
- Over the past year, NRXP quarterly short term debt has dropped by -$3.10 million (-45.66%).
- NRXP quarterly short term debt is now -70.97% below its all-time high of $12.69 million, reached on June 30, 2023.
Performance
NRXP Quarterly Short Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Short Term Debt Formula
Short-Term Debt = Current Portion of Long-Term Debt + Short-Term Loans + Commercial Paper + Other Short-Term Borrowings
NRXP Short Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.9% | -45.7% |
| 3 y3 years | +3579.1% | +100.0% |
| 5 y5 years | +3579.1% | - |
NRXP Short Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1668.5% | -71.0% | -100.0% |
| 5 y | 5-year | at high | +3579.1% | -71.0% | -100.0% |
| alltime | all time | at high | +3579.1% | -71.0% | -100.0% |
NRx Pharmaceuticals Short Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.68 M(-51.8%) |
| Jun 2024 | - | $7.65 M(+12.9%) |
| Mar 2024 | - | $6.78 M(-26.0%) |
| Dec 2023 | $9.16 M(+18.9%) | $9.16 M(-9.0%) |
| Sep 2023 | - | $10.07 M(-20.7%) |
| Jun 2023 | - | $12.69 M(+4.1%) |
| Mar 2023 | - | $12.19 M(+58.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $7.70 M(+1387.1%) | $7.70 M(>+9900.0%) |
| Sep 2022 | - | $0.00(0.0%) |
| Jun 2022 | - | $0.00(-100.0%) |
| Mar 2022 | - | $520.00 K(+0.4%) |
| Dec 2021 | $518.00 K(+108.0%) | $518.00 K(+0.6%) |
| Sep 2021 | - | $515.10 K(+196.5%) |
| Jun 2021 | - | $173.70 K(-30.2%) |
| Dec 2020 | $249.00 K | $249.00 K |
FAQ
- What is NRx Pharmaceuticals annual short term debt?
- What is the all time high annual short term debt for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals annual short term debt year-on-year change?
- What is NRx Pharmaceuticals quarterly short term debt?
- What is the all time high quarterly short term debt for NRx Pharmaceuticals?
- What is NRx Pharmaceuticals quarterly short term debt year-on-year change?
What is NRx Pharmaceuticals annual short term debt?
The current annual short term debt of NRXP is $9.16 M
What is the all time high annual short term debt for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high annual short term debt is $9.16 M
What is NRx Pharmaceuticals annual short term debt year-on-year change?
Over the past year, NRXP annual short term debt has changed by +$1.46 M (+18.93%)
What is NRx Pharmaceuticals quarterly short term debt?
The current quarterly short term debt of NRXP is $3.68 M
What is the all time high quarterly short term debt for NRx Pharmaceuticals?
NRx Pharmaceuticals all-time high quarterly short term debt is $12.69 M
What is NRx Pharmaceuticals quarterly short term debt year-on-year change?
Over the past year, NRXP quarterly short term debt has changed by -$3.10 M (-45.66%)